Darunavir

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Darunavir and local guidelines before prescribing.

Protease inhibitor

Mechanism

Protease inhibitor (boosted).

Uses

HIV infection.

Dosing

Side effects

Diarrhoea, nausea, rash, raised lipids.

Interactions

Boosted: many CYP3A4 interactions.

Contraindications and cautions

Severe liver impairment

Monitoring

LFT, lipids

Pregnancy and breastfeeding

Used in pregnancy

Renal and hepatic impairment

Avoid in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

Sulfonamide allergy caution.

More from the textbook: uses, cautions and other points
Where it is discussed in the book